Literature DB >> 8682592

Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review.

R Montesano1, M Hollstein, P Hainaut.   

Abstract

Cancer of the esophagus exists in 2 main forms with different etiological and pathological characteristics-squamous cell carcinoma (SCC) and adenocarcinoma (ADC). This review focuses on the occurrence of genetic alterations in SSC and ADC of the esophagus and on their possible implications for the elucidation of the etiology and pathogenesis of these cancers. The most common alterations found in esophageal cancers include allelic losses at chromosomes 3p, 5q, 9p, 9q, 13q, 17p, 17q and 18q, as well as mutations of p53 (mostly missense), Rb (deletions), cyclin DI (amplifications) and c-myc (amplifications). The sequence of occurrence of these alterations with respect to histopathological tumor progression is discussed. Our findings underscore the different etiology and pathogenesis of SCC vs. ADC and suggest that the genetic alterations observed may represent molecular fingerprints of critical risk involved in the development of these 2 cancers.

Entities:  

Mesh:

Year:  1996        PMID: 8682592     DOI: 10.1002/(SICI)1097-0215(19960621)69:3<225::AID-IJC13>3.0.CO;2-6

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  58 in total

Review 1.  Soft tissue sarcomas and p53 mutations.

Authors:  H Taubert; A Meye; P Würl
Journal:  Mol Med       Date:  1998-06       Impact factor: 6.354

Review 2.  Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.

Authors:  J A Jankowski; N A Wright; S J Meltzer; G Triadafilopoulos; K Geboes; A G Casson; D Kerr; L S Young
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

3.  Molecular biology of Barrett's esophagus and esophageal cancer:role of p53.

Authors:  Alan G Casson
Journal:  World J Gastroenterol       Date:  1998-08       Impact factor: 5.742

4.  Association of p53/p21 expression with cigarette smoking and prognosis in esophageal squamous cell carcinoma patients.

Authors:  Noushin Taghavi; Firouzeh Biramijamal; Masoud Sotoudeh; Omeed Moaven; Hooman Khademi; Mohammad Reza Abbaszadegan; Reza Malekzadeh
Journal:  World J Gastroenterol       Date:  2010-10-21       Impact factor: 5.742

5.  The tumor suppressor LKB1 antagonizes WNT signaling pathway through modulating GSK3β activity in cell growth of esophageal carcinoma.

Authors:  Kai Liu; Yue Luo; Hui Tian; Kai-Zhong Yu; Jin-Xian He; Wei-Yu Shen
Journal:  Tumour Biol       Date:  2014-02

6.  Specific mutation screening of TP53 gene by low-density DNA microarray.

Authors:  Angélica Rangel-López; Alfonso Méndez-Tenorio; Kenneth L Beattie; Rogelio Maldonado; Patricia Mendoza; Guelaguetza Vázquez; Carlos Pérez-Plasencia; Martha Sánchez; Guillermo Navarro; Mauricio Salcedo
Journal:  Nanotechnol Sci Appl       Date:  2009-01-20

7.  Effects of ROCK inhibitor, Y-27632, on adhesion and mobility in esophageal squamous cell cancer cells.

Authors:  Lili Wang; Lexun Xue; Hongxia Yan; Jie Li; Yucheng Lu
Journal:  Mol Biol Rep       Date:  2009-08-02       Impact factor: 2.316

8.  Using yeast two-hybrid system to identify ECRG2 associated proteins and their possible interactions with ECRG2 gene.

Authors:  Yong-Ping Cui; Jian-Bo Wang; Xin-Yu Zhang; Mei-Xia Bi; Li-Ping Guo; Shih-Hsin Lu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

9.  p53 alterations in oesophageal cancer: association with clinicopathological features, risk factors, and survival.

Authors:  A G Casson; M Tammemagi; S Eskandarian; M Redston; J McLaughlin; H Ozcelik
Journal:  Mol Pathol       Date:  1998-04

10.  Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpression.

Authors:  Jonine D Figueroa; Mary Beth Terry; Marilie D Gammon; Thomas L Vaughan; Harvey A Risch; Fang-Fang Zhang; David E Kleiner; William P Bennett; Christine L Howe; Robert Dubrow; Susan T Mayne; Joseph F Fraumeni; Wong-Ho Chow
Journal:  Cancer Causes Control       Date:  2008-11-07       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.